U-Blot® Research Grade Anti-Human CD272/BTLA Antibody (22B3)Cat. No. WA1504Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD272/BTLA Antibody (22B3)Cat. No. WA1504
U-Blot® Research Grade Anti-Human CD272/BTLA (LY3361237)Cat. No. WA1503
U-Blot® Research Grade Anti-Human CD272/BTLA (ANB032)Cat. No. WA1502
U-Blot® Research Grade Anti-Human CD27 Antibody (M2191)Cat. No. WA1501
U-Blot® Research Grade Anti-Human CD27 Antibody (M2177)Cat. No. WA1500
U-Blot® Research Grade Anti-Human CD269/TNFRSF17/BCMA Antibody (SEA-BCMA)Cat. No. WA1499
U-Blot® Research Grade Anti-Human CD269/TNFRSF17/BCMA Antibody (BCMB69)Cat. No. WA1498
U-Blot® Research Grade Anti-Human CD269/TNFRSF17/BCMA (TBL-CLN1)Cat. No. WA1497
U-Blot® Research Grade Anti-Human CD269/TNFRSF17/BCMA (SGN-BCMA)Cat. No. WA1496
U-Blot® Research Grade Anti-Human CD269/TNFRSF17/BCMA (PRG1801)Cat. No. WA1495
U-Blot® Research Grade Anti-Human CD269/TNFRSF17/BCMA (MEDI2228)Cat. No. WA1494
U-Blot® Research Grade Anti-Human CD269/TNFRSF17/BCMA (LCAR-B38M)Cat. No. WA1493